Cited by 574Asthma and respiratory diseasesOccupational exposure and asthmaRespiratory and Cough-Related Research

The DOI matches its Crossref record.

Alternative excitotoxic hypotheses

Albin, Roger L., Greenamyre, J. Timothy·1992·Neurology

Open this paper in CoChat — free account

Abstract

It is known that asthma is a heterogeneous entity whose manifestations vary with age. Our objective was to examine changes in the manifestation of asthma and asthma-related traits in childhood by defining empirically derived childhood asthma phenotypes and examining their transitions over time. To define the phenotypes we used data on respiratory symptoms, healthcare utilisation, medications, spirometry, airway hyperresponsiveness (AHR), exhaled nitric oxide concentration and atopy from a birth cohort recruited on the basis of having a first-degree relative with asthma. Data were acquired at ages 1.5–11.5 years and analysed using latent transition analysis. In a study population of 370 participants, we classified subjects into four phenotypes: 1) nonatopic, few symptoms (prevalence range from 1.5 to 5 years: 52–60%), 2) atopic, few symptoms (3–21%), 3) nonatopic, asthma and rhinitis symptoms (13–35%), and 4) atopic, asthma and rhinitis symptoms (2–14%) in early childhood; and 1) nonatopic, no respiratory disease (prevalence range from 8 to 11.5 years: 41–46%), 2) atopic, no respiratory disease (23–33%), 3) nonatopic, asthma symptoms, no AHR or airway inflammation (8–12%) and 4) atopic asthma (19%) in mid-childhood. Transitioning between phenotypes was common in early childhood, but less common in later childhood. This analysis represents the first attempt to incorporate longitudinal patterns of several manifestations of asthma into a single model to simultaneously define phenotypes and examine their transitions over time. It provides quantitative support for the view that asthma is a heterogeneous entity, and that some children with wheeze and other respiratory symptoms in early life progress to asthma in mid-childhood, while others become asymptomatic.

Integrity signals

Registry

Crossref · 10.1212/wnl.42.4.733

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 501–573 of 573

Replicating Huntington Disease’s Phenotype in Nonhuman Primates
Hantraye, P., Palfi, S., Mittoux, V., Dautry, C., Condé, F., & Brouillet, E. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_17 · Cited by 1
Brain Magnetic Resonance Imaging in Attention-Deficit/Hyperactivity Disorder (ADHD)
Fayed, N. M., Morales, H., Torres, C., Fayed, A., & Rios, L. F. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-61721-9_44 · Cited by 1
Ischemic Injury to White Matter: An Age-Dependent Process
Brunet, S., Bastian, C., & Baltan, S. (2016) · Springer series in translational stroke research · doi:10.1007/978-3-319-32337-4_16 · Cited by 1
FUNCTIONAL PROPERTIES OF L-GLUTAMATE REGULATION IN ANESTHETIZED AND FREELY MOVING MICE
Hascup, K. N. (2007) · UKnowledge (University of Kentucky) · Cited by 1
Survey of the Spectrum of Classic Selective Neurotoxins
Kostrzewa, R. M. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_246 · Cited by 1
Glutamate Receptors and Excitotoxic Mechanisms in Alzheimer’s Disease
Geddes, J. W. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_18 · Cited by 1
Disease Modifying Agents for Huntington??s Disease
Clarke, H., & Feigin, A. (1999) · CNS Drugs · doi:10.2165/00023210-199912050-00005 · Cited by 1
Calcium Channel Dysfunction in Huntington’s Disease
Cherry, S. (2009) · doi:10.21007/etd.cghs.2009.0051 · Cited by 1
“One of the major excitatory inputs that striatal projection neurons receive is from corticostriatal afferents (Albin and Greenamyre, 1992; Bolam et al., 2000).”
Background
The Neuroprotective Properties of Creatine in Animal Models of Neurodegenerative Diseases
Kaddurah-Daouk, R. F., Matthews, R., & Beal, M. F. (2000) · Medical science symposia series · doi:10.1007/978-94-011-4237-3_13 · Cited by 1
Metabolic Abnormalities in Alzheimer Disease
Gebhardt, F. M., & Dodd, P. R. (2008) · Springer eBooks · doi:10.1007/978-0-387-79112-8_22 · Cited by 1
“Cell loss is particularly severe in pyramidal neurons in layers III and IV of the neocortex, as well as in glutamate-innervated cortical and hippocampal neurons (Albin and Greenamyre, 1992) .”
Background
Gene and Protein Expression and Regulation in the Central Nervous System
Kubin, L. K., Gozal, D., & Czyzyk-Krzeska, M. (2002) · Lung biology in health and disease · doi:10.1201/9780203910504.ch5 · Cited by 2
10
(2005) · CRC Press eBooks · doi:10.1201/b12189-10 · Cited by 1
Novel Systems for the Study of Human Disease
OECD (1998) · OECD eBooks · doi:10.1787/9789264162389-en · Cited by 1
Intrastriatal Injections of Quinolinic Acid as a Model for Developing Neuroprotective Strategies in Huntington’s Disease
Emerich, D. F. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_15 · Cited by 1
Antagonists of Excitatory Amino Acid Receptors in the Treatment of Parkinson’s Disease
Bonuccelli, U., & Dotto, P. D. (1994) · Advances in behavioral biology · doi:10.1007/978-1-4613-0485-2_58 · Cited by 1
The molecular pathogenesis of Huntington’s disease
Turner, C. D. (2009) · UCL Discovery (University College London)
Neurotrophic Factors, Encapsulated Cells, and ALS
Braguglia, D., & Aebischer, P. (1999) · Elsevier eBooks · doi:10.1016/b978-012705070-6/50024-x
Molecular and Cellular Characterization of Dopamine Neuron Stimulating Peptides
Kelps, K. A. (2013) · UKnowledge (University of Kentucky)
Oxidant-Mediated Repression of Mitochondrial DNA Transcription
Kristal, B. S., & Yu, B. P. (2000) · Elsevier eBooks · doi:10.1016/b978-012636670-9/50022-2
A Gene Therapy Approach for the Treatment of ALS
Aebischer, P., & Braguglia, D. (1998) · Springer eBooks · doi:10.1007/978-3-642-72160-1_16
“The glutamate excitotoxicity can also be exerted by the so called weak excitotoxic pathway (Albin and Greenamyre, 1992) with normal concentration of glutamate becoming neurotoxic on metabolically compromised neurons.”
Background
Excitotoxins, nitric oxide and programmed neuronal death
Leist, M., & Nicotera, P. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)05012-x
DISRUPTIONS IN THE REGULATION OF EXTRACELLULAR GLUTAMATE IN THE RAT CENTRAL NERVOUS SYSTEM AFTER DIFFUSE BRAIN INJURY
Hinzman, J. M. (2012) · UKnowledge (University of Kentucky)
Propriedades redox de canais de potássio mitocondriais ATP-sensíveis em cérebro de seu efeito neuroprotetor em excitotoxicidade
Fornazari, M. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2008.tde-27112008-144745
Interactions between neuronal nicotinic acetylcholine receptors, N-Methyl-Aspartate receptors and beta-amyloid in the brain of genetically modified mice : Implications for Alheimer´s disease
Lithner, C. U. (2005) · Figshare
Efeitos comportamentais e bioquímicos da dieta intermitente na vigência de um estímulo inflamatório no hipocampo de ratos.
Vasconcelos, A. R. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2011.tde-10022012-100857
Ion Channels and Molecular Events in Neuronal Activity
Kolb, B. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-097086-8.55031-4
Chapter 2 The Neuronal Cytoskeleton: Changes Associated with Age, Neurodegenerative Disease, and Neuronal Insult
Geddes, J. W., & Matus, A. I. (1997) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60052-8
3 Neurotransmitter dynamics in cerebral ischaemia
Obrenovitch, T. P., & Richards, D. A. (1996) · Baillière s Clinical Anaesthesiology · doi:10.1016/s0950-3501(96)80027-4
ANIMAL MODELS FOR HUNTINGTON’S DISEASES: A REVIEW
Manisha, S., & Sunil, K. (2012) · International Research Journal of Pharmacy
Bioenergetic Defects and Oxidative Damage in Transgenic Mouse Models of Neurodegenerative Disorders
Browne, S. E. (2003) · Defense Technical Information Center (DTIC) · doi:10.21236/ada419306
Murine Models of Huntington Disease
Sturrock, A., & Leavitt, B. R. (2009) · Future Neurology · doi:10.2217/fnl.09.34
Role of Dopaminergic and Glutamatergic Systems of the Striatum in the Mechanisms of d-Amphetamine and Ammonia Neurotoxicity
Anderzhanova, E. A. (2003) · Tampere University Institutional Repository (Tampere University)
El núcleo subtalámico en la fi siopatología de la enfermedad de Parkinson y su rol como diana quirúrgica The subthalamic nucleus in the pathophysiology of Parkinson's disease and its role as a surgical target
Herrera, C. R. M. (2011)
NeurodegenerationinStriatumInducedbythe MitochondrialToxin3-NitropropionicAcid:RoleofMatrix Metalloproteinase-9inEarlyBlood-Brain BarrierDisruption?
Kim, G. (2003)
Efeitos in vivo do ácido metilmalônico sobre o comportamento de ratos no labirinto aquático de morris e in vitro sobre alguns parâmetros de estresse oxidativo e sobre as atividades dos complexos I-IV da cadeia respiratória em homogeneizado de tecidos de ratos
Pettenuzzo, L. F. (2006) · Americanae (AECID Library)
Eine epidemiologische Studie im süddeutschen Raum
Rehm, M. M. (2004)
3-Nitropropionic Acid and Other Metabolic Toxin Lesions of the Striatum
Borlongan, C. V., & Sanberg, P. R. (2011) · Neuromethods · doi:10.1007/978-1-61779-301-1_5
NFkB and Neurotoxicity
Kassed, C. A., Butler, T. L., & Pennypacker, K. R. (2004) · Informa Healthcare eBooks · doi:10.1201/9780203503317.ch4
Intermittent hypoxia and neurocognitive function
Gozal, D., Gozal, D., Wang, Y., & Zhang, S. X. L. (2011) · Informa Healthcare eBooks · doi:10.3109/9781420020885.015
INTRODUCTIONAND HISTORICAL NOTES EXCITOTOXICITY IN NEUROLOGIC DISEASES
Beal, M. F. (2004)
Measurement of Spine Density in Mouse Models of Hypodopaminergia
Bermejo, M. K. (2013) · TSpace (University of Toronto)
Cyclosporin A Protects Striatal Neurons from Mitochondrial Dysfunction
Leventhal, L., & Kordower, J. H. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-315-6_8
The Role of Mitochondrial Mutations in Sensorineural Hearing Loss
Reid, F. M. (1995) · Enlighten: Theses (The University of Glasgow)
A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars Compacta in Parkinson's DiseasePreprint
Muddapu, V. R., Vijayakumar, K., Ramakrishnan, K., & Chakravarthy, V. S. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2004.08320 · Cited by 1
“s) which are already in a low energy state. Due to disinhibition and energy deficiency, SNc somas might become overactive, which leads to calcium build-up, resulting in excitotoxic loss of SNc somas (Albin and Greenamyre, 1992; Muddapu et al., 2019). When higher concentrations of extracellular LDOPA were available, th…”
BackgroundResult
Huntington's Disease
Browne, S. E., & Beal, M. F. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50051-2
Ischemia-Induced Ionic Mechanisms of Injury in the Developing Brain
Tasker, R. C. (2001) · Brain Injury · doi:10.1007/978-1-4615-1721-4_11
EFEITOS COMPORTAMENTAIS E BIOQUÍMICOS DA DIETA INTERMITENTE NA VIGÊNCIA DE UM ESTÍMULO INFLAMATÓRIO NO HIPOCAMPO DE RATOS
Paulo, S. (2011)
The Neuropeptide Kyotorphin as a Possible Biomarker and Neuroprotective Agent in Alzheimer’s Disease
Angelova, H., Pechlivanova, D., Landzhov, B. V., et al. (2020) · Journal of Biomedical and Clinical Research · doi:10.2478/jbcr-2020-0002
Glutamato: Aspectos Neuronales
Sonia Luz Albarracín, C., & Lareo, L. (2021) · Editora Blucher eBooks · doi:10.5151/9786555500950-08
Neuropharmacology
Wenk, G. L., & Marchalant, Y. (2009) · doi:10.1002/9780470478509.neubb001006 · Cited by 1
Glutamato: Aspectos Neuronais
Sonia Luz Albarracín, C., & Lareo, L. (2021) · Editora Blucher eBooks · doi:10.5151/9786555500967-08
The paradigm of Huntington’s disease: Therapeutic opportunities in neurodegeneration
Leegwater‐Kim, J., & Cha, J.-H. J. (2004) · Neurotherapeutics · doi:10.1007/bf03206573
Post-Hypoxic-Ischemic Damage
(2005) · Springer eBooks · doi:10.1007/3-540-27660-2_94
Malonate
Meldrum, A., Page, K. J., Everitt, B. J., & Dunnett, S. B. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_14
Caffeine and Parkinson’s Disease
Ascherio, A., & Schwarzschild, M. A. (2004) · Nutrition, brain, and behavior./Nutrition, brain and behavior · doi:10.1201/9780203618851.ch10
Long-term Neurocognitive Outcomes after Pediatric Intensive Care Unit Admission: Exploring the Role of Drug ExposurePreprint
de Sonnaville, E. S. V., Oosterlaan, J., Ghiassi, S. A., van Leijden, O., van Ewijk, H., Knoester, H., van Woensel, J. B. M., & Königs, M. (2022) · medRxiv · doi:10.1101/2022.06.29.22277048
Survey of the Spectrum of Classic Selective Neurotoxins
Kostrzewa, R. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-71519-9_246-1
Transformation of Brain Function Associated With Spiritual Experience
Newberg, A. B. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190905538.013.25
A cholesterol-coupled N-acetyl-aspartyl-glutamate metabolic network facilitates the neuroprotective impact of estradiol in neuronsPreprint
Chow, H., Sun, J. K., Wu, D., Peng, A. Z., Wong, G. C., Hart, R. P., & Herrup, K. (2024) · Research Square · doi:10.21203/rs.3.rs-4489289/v1
NEUROPROTECTIVE EFFECT OF THYROTROPIN-RELEASING HORMONE (TRH) AGAINST GLUTAMATE TOXICITY IN VITRO
Yard, M. (2009) · doi:10.7912/c2/2037
Receptor targets in Alzheimer's disease drug discovery
Stanley, B., Wallach, J. V., & Adejare, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30008-0.00013-2
Huntingtin-Associated Proteins
MacDonald, M. E., Passani, L. A., & Hilditch-Maguire, P. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-006-3_15
Additional file 8 of Intelligence outcome of pediatric intensive care unit survivors: a systematic meta-analysis and meta-regression
de Sonnaville, E. S. V., Königs, M., van Leijden, O., Knoester, H., van Woensel, J. B. M., & Oosterlaan, J. (2022) · Figshare · doi:10.6084/m9.figshare.19946274
Additional file 10 of Intelligence outcome of pediatric intensive care unit survivors: a systematic meta-analysis and meta-regression
de Sonnaville, E. S. V., Königs, M., van Leijden, O., Knoester, H., van Woensel, J. B. M., & Oosterlaan, J. (2022) · Figshare · doi:10.6084/m9.figshare.19946247
Additional file 1 of Intelligence outcome of pediatric intensive care unit survivors: a systematic meta-analysis and meta-regression
de Sonnaville, E. S. V., Königs, M., van Leijden, O., Knoester, H., van Woensel, J. B. M., & Oosterlaan, J. (2022) · Figshare · doi:10.6084/m9.figshare.19946250
Additional file 2 of Intelligence outcome of pediatric intensive care unit survivors: a systematic meta-analysis and meta-regression
de Sonnaville, E. S. V., Königs, M., van Leijden, O., Knoester, H., van Woensel, J. B. M., & Oosterlaan, J. (2022) · Figshare · doi:10.6084/m9.figshare.19946253
Additional file 4 of Intelligence outcome of pediatric intensive care unit survivors: a systematic meta-analysis and meta-regression
de Sonnaville, E. S. V., Königs, M., van Leijden, O., Knoester, H., van Woensel, J. B. M., & Oosterlaan, J. (2022) · Figshare · doi:10.6084/m9.figshare.19946259
Additional file 7 of Intelligence outcome of pediatric intensive care unit survivors: a systematic meta-analysis and meta-regression
de Sonnaville, E. S. V., Königs, M., van Leijden, O., Knoester, H., van Woensel, J. B. M., & Oosterlaan, J. (2022) · Figshare · doi:10.6084/m9.figshare.19946271
Additional file 3 of Intelligence outcome of pediatric intensive care unit survivors: a systematic meta-analysis and meta-regression
de Sonnaville, E. S. V., Königs, M., van Leijden, O., Knoester, H., van Woensel, J. B. M., & Oosterlaan, J. (2022) · Figshare · doi:10.6084/m9.figshare.19946256
Additional file 6 of Intelligence outcome of pediatric intensive care unit survivors: a systematic meta-analysis and meta-regression
de Sonnaville, E. S. V., Königs, M., van Leijden, O., Knoester, H., van Woensel, J. B. M., & Oosterlaan, J. (2022) · Figshare · doi:10.6084/m9.figshare.19946265
Additional file 5 of Intelligence outcome of pediatric intensive care unit survivors: a systematic meta-analysis and meta-regression
de Sonnaville, E. S. V., Königs, M., van Leijden, O., Knoester, H., van Woensel, J. B. M., & Oosterlaan, J. (2022) · Figshare · doi:10.6084/m9.figshare.19946262
Ion Channels and Molecular Events in Neuronal Activity
Walsh, J. P. (2001) · Elsevier eBooks · doi:10.1016/b0-08-043076-7/03440-9
REGIONAL HETEROGENEITY AND DIVERSITY OF ASTROCYTES IN RESPONSE TO HIV-1 PROTEINS AND MORPHINE
Chen, W. (2010) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/aq65-x063

Authors: Albin, R. L., & Greenamyre, J. T.
Affiliations: University of Michigan (US)
University of Rochester (US)
ORCID: Albin, Roger L.
Greenamyre, J. Timothy
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1992-04
Volume: 42
Issue: 4
Pages: 733-733
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.42.4.733
OpenAlex: W2058176457
Cited by: 574
References: 0
Citations by year: 2026: 1 · 2025: 3 · 2024: 6 · 2023: 3 · 2022: 18 · 2021: 4 · 2020: 12 · 2019: 3 · 2018: 6 · 2017: 7 · 2016: 5 · 2015: 4 · 2014: 10 · 2013: 12 · 2012: 16
FWCI: 14.01
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5k08ns001300-03, 5k08ns001487-03)
National Institute of Neurological Disorders and Stroke (NS01300, NS 01487)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory and Cough-Related Research
Keywords: asthma phenotypes, childhood asthma, asthma heterogeneity, phenotype transition, atopy, rhinitis, airway hyperresponsiveness, exhaled nitric oxide, wheezing, latent transition analysis, birth cohort
MeSH terms: Acute Disease, Amino Acids, Chronic Disease, Humans, Models, Neurological, Nerve Degeneration, Nervous System Diseases, Neurology, Neurotoxins, Receptors, Cell Surface, Receptors, Amino Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Alternative excitotoxic hypotheses

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks